Physician profile
Jane E Archer
NPI 1619237476
$5,711.47
in general payments reported to CMS, 2019-2025
6 companies · $2,580 in 2025
The $2,580 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $151 · 2023: $2,875 · 2024: $106 · 2025: $2,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,119 · Food and Beverage: $2,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,118.64 |
| Food and Beverage | $2,442.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $5,235.13 | 2022-2025 | Xeomin |
| Novo Nordisk INC | $210.97 | 2022-2025 | Wegovy, Saxenda |
| Revance Therapeutics, INC. | $159.02 | 2025 | Daxxify |
| Lilly USA, LLC | $53.99 | 2024-2025 | Zepbound, Mounjaro |
| Currax Pharmaceuticals LLC | $39.20 | 2022-2025 | Contrave |
| Acella Pharmaceuticals, LLC | $13.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Archer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.